Predicting reattendance at a high-risk breast cancer clinic

Palliative & Supportive Care
Sarah R OrmsethTaylor L Draper

Abstract

The research about follow-up patterns of women attending high-risk breast-cancer clinics is sparse. This study sought to profile daughters of breast-cancer patients who are likely to return versus those unlikely to return for follow-up care in a high-risk clinic. Our investigation included 131 patients attending the UCLA Revlon Breast Center High Risk Clinic. Predictor variables included age, computed breast-cancer risk, participants' perceived personal risk, clinically significant depressive symptomatology (CES-D score ≥ 16), current level of anxiety (State-Trait Anxiety Inventory), and survival status of participants' mothers (survived or passed away from breast cancer). A greater likelihood of reattendance was associated with older age (adjusted odds ratio [AOR] = 1.07, p = 0.004), computed breast-cancer risk (AOR = 1.10, p = 0.017), absence of depressive symptomatology (AOR = 0.25, p = 0.009), past psychiatric diagnosis (AOR = 3.14, p = 0.029), and maternal loss to breast cancer (AOR = 2.59, p = 0.034). Also, an interaction was found between mother's survival and perceived risk (p = 0.019), such that reattendance was associated with higher perceived risk among participants whose mothers survived (AOR = 1.04, p = 0.002), but...Continue Reading

References

Jan 1, 1992·Journal of the National Cancer Institute·K M KashD G Miller
May 1, 1990·Preventive Medicine·C LermanP F Engstrom
Jan 1, 1994·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·F BasoloF Pacini
Feb 2, 1994·Journal of the National Cancer Institute·F X Mahaney
Jul 7, 1993·Journal of the National Cancer Institute·C LermanP Engstrom
Nov 1, 1995·Journal of Shoulder and Elbow Surgery·G M Gartsman, J C Milne
Nov 1, 1996·Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association·K D McCaulP A Reid
Jan 19, 1999·Journal of Behavioral Medicine·K D McCaulK B Quinlan
Jun 9, 1999·The American Journal of Psychiatry·K S KendlerC A Prescott
May 19, 2000·Breast Cancer Research and Treatment·B MeiserK Tucker
Aug 23, 2000·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·C La Vecchia
Aug 23, 2000·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·B KuschelM W Beckmann
Jan 5, 2002·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·N M Lindberg, D Wellisch
Jul 4, 2003·Women & Health·Sherri Sheinfeld Gorin, Steven M Albert
Jul 31, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J-L BulliardF Levi
Dec 9, 2003·The Breast : Official Journal of the European Society of Mastology·R K TatlaVerna Mai
Sep 1, 2004·Consciousness and Cognition·Mark R SmithRebecca N Emery
Jul 22, 2008·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Kelly A TracyJoann Bodurtha
Apr 7, 2010·Breast Cancer Research and Treatment·Melanie A PriceUNKNOWN kConFab Investigators
Apr 7, 2011·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·Li Rita ZhangPaul Ritvo
Jan 15, 2013·The Breast : Official Journal of the European Society of Mastology·Meghan J WalkerPaul Ritvo

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.